Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Drugs Under Experimental and Clinical Research|January 1, 1990
Biological activity of the main metabolites of meloxicamG Engelhardt, G TrummlitzCurrent Medicinal Chemistry|October 18, 2000
COX-2 selectivity and inflammatory processesJ van Ryn, G Trummlitz, M PairetArzneimittel-Forschung|January 1, 1984
Conformational analysis of the antiulcer drug pirenzepine. X-ray investigations, molecular mechanics and quantum mechanical calculations and comparisons with structurally or pharmacologically related compoundsG Trummlitz, G Schmidt, H U Wagner, et al.Journal of Medicinal Chemistry|August 1, 1989
Tricyclic compounds as selective muscarinic receptor antagonists. 3. Structure-selectivity relationships in a series of cardioselective (M2) antimuscarinicsW W Engel, W G Eberlein, G Mihm, et al.Journal of Medicinal Chemistry|June 1, 1988
Tricyclic compounds as selective antimuscarinics. 2. Structure-activity relationships of M1-selective antimuscarinics related to pirenzepineW G Eberlein, W W Engel, G Trummlitz, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 1995
Meloxicam: metabolic profile and biotransformation products in the ratJ Schmid, U Busch, G Trummlitz, et al.Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|July 31, 1998
Differential inhibition of cyclooxygenases-1 and -2 by meloxicam and its 4'-isomerM Pairet, J van Ryn, H Schierok, et al.Arzneimittel-Forschung|January 1, 1985
Conformational studies of two histamine H2-receptor antagonistic phenylformamidines: mifentidine and its guanidinothiazole analogue DA 4643A Donetti, G Trummlitz, G Bietti, et al.Journal of Medicinal Chemistry|August 1, 1987
Tricyclic compounds as selective antimuscarinics. 1. Structural requirements for selectivity toward the muscarinic acetylcholine receptor in a series of pirenzepine and imipramine analoguesW G Eberlein, G Trummlitz, W W Engel, et al.Journal of Medicinal Chemistry|March 14, 1997
Effect of structural modification of enol-carboxamide-type nonsteroidal antiinflammatory drugs on COX-2/COX-1 selectivityE S Lazer, C K Miao, C L Cywin, et al.Pageof 1